David Linetsky, SVP, Life Sciences at Phreesia, Inc. (PHR), sold 6,987 shares at $23.66 ($166K) on 2025-04-16, disclosed to the SEC on 2025-04-17.
Scheduled sale ($166k) by SVP, Life Sciences under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.66 | 2,488 | $59K | 35.5% |
| 2 | $23.66 | 2,488 | $59K | 35.5% |
| 3 | $23.81 | 2,011 | $48K | 28.9% |
| Total | $23.70 avg | 6,987 | $166K | 100% |
| Filing → |
| PHR | SELL | 2026-01-20 | $127K | — | Filing → |
| PHR | SELL | 2026-01-12 | $104K | — | Filing → |
| PHR | SELL | 2025-12-19 | $2K | — | Filing → |